First patients dosed in trial of Telix’s cancer imaging therapy

Nuclear oncology company Telix Pharmaceuticals (ASX:TLX) says the first two patients with advanced lung or ovarian cancer have been dosed … Read More

The post First patients dosed in trial of Telix’s cancer imaging therapy appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *